|
Average age (years) (range)
|
55.17 ± 9.06 (33–79)
|
|
60 years
|
21
|
|
≥ 60 years
|
6
|
|
Menstrual state
|
|
Premenopausal
|
9
|
|
Postmenopausal
|
18
|
|
Pathological subtype
|
|
Invasive ductal carcinoma
|
26
|
|
Invasive lobular carcinoma
|
1
|
|
Primary tumor size (cm)
|
|
2
|
15
|
|
2–5
|
6
|
|
≥ 5
|
5
|
|
Invasion of chest wall skin
|
1
|
|
Axillary metastatic lymph nodes (number)
|
|
0
|
14
|
|
1–34
|
8
|
|
≥ 4
|
5
|
|
ER/PR
|
|
+
|
18
|
|
−
|
9
|
|
Her-2
|
|
+
|
15
|
|
−
|
12
|
|
Time to postoperative liver metastasis (months)
|
|
< 24
|
16
|
|
≥ 24
|
11
|
|
Intrahepatic lesions (number)
|
|
Single
|
5
|
|
Multiple
|
22
|
|
Intrahepatic lesion size (cm)
|
|
3
|
3
|
|
≥ 3
|
24
|
|
Whether combination therapy was adopted
|
|
Yes
|
18
|
|
No
|
9
|
|
Whether complicated by extrahepatic metastasis
|
|
Yes
|
16
|
|
No
|
11
|
|
Number of interventional treatment sessions (range)
|
2.44 ± 1.58 (1–6)
|
